Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 239

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 239
---
 June30, 2023. The unaudited pro forma combined statement of operations was prepared giving pro forma effect to the Business Combination as if it had occurred on July 1, 2023, the beginning of the earliest period presented. For more information about the Business Combination see “ The Business Combination.” The unaudited pro forma combined financial information has been prepared assuming: • Scenario 1 — Assuming no redemptions for cash: This presentation assumes that no SPAC Shareholders exercise redemption rights with respect to their SPAC Ordinary Shares upon consummation of the Business Combination and considers that the obligations under the Backstop Agreement will be satisfied by making a cash contribution in an amount of up to $10,000,000 to OmnigenicsAI Corp. See “ Certain Agreements Related to the Business Combination — Backstop Agreement;” • Scenario 2 — Assuming redemptions of 50% of the outstanding Public Shares for cash: This presentation assumes that holders of Public Shares exercise their redemption rights with respect to 50% of the Public Shares upon consummation of the Business Combination at a redemption price of approximately $12.05 per share as of December 31, 2024 (fair value as of said date). Scenario 2 includes all adjustments contained in Scenario 1 and presents additional adjustments to reflect the effect of the redemptions of 50% of the Public Shares and assumes that the obligations under the Backstop Agreement will be satisfied by making a cash contribution in an amount of up to $10,000,000 to OmnigenicsAI Corp. See “ Certain Agreements Related to the Business Combination — Backstop Agreement;” and • Scenario 3 — Assuming redemptions of 100% of outstanding Public Shares for cash: This presentation assumes that holders of Public Shares exercise their redemption rights with respect to a maximum of 100% of the Public Shares upon consummation of the Business Combination at a redemption price of approximately $12.05 per share as of December 31, 2024 (fair value as of said date). Scenario 3 includes all adjustments contained in Scenario1, presents additional adjustments to reflect the effect of the maximum redemptions and assumes that the obligations under the Backstop Agreement will be satisfied 99 by making a cash contribution in an amount of $10,000,000 to OmnigenicsAI, considering that there will be no remaining balance in the Trust Account after payment in full of the SPAC Shareholder Redemption Amount. See “ Certain Agreements Related to the Business